Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Income from Discontinued Operations (2015 - 2016)

Updated

Sinovac Biotech (SVA) reported Income from Discontinued Operations of -$2.34 million for Q4 2016, compared with -$447,000 a year earlier.

Analysis

Sinovac Biotech (SVA) Income from Discontinued Operations (2015 - 2016) Analysis & Trends

For FY2015, Sinovac Biotech posted Income from Discontinued Operations of -$728,000.

  • By year, Income from Discontinued Operations came in at -$1.52 million in FY2014, -$1.27 million in FY2013, -$80.00 in FY2012 and -$40.00 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Sinovac Biotech 464.94 Mn -24.98 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -2.34 Mn
Mar 31, 2016 2.34 Mn
Dec 31, 2015 -447,000.00
Sep 30, 2015 -265,000.00
Jun 30, 2015 -244,000.00
Mar 31, 2015 -202,000.00
API Access

Sinovac Biotech Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=SVA&period=max&api_key=YOUR_API_KEY